Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Net Cash Flow (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Net Cash Flow for 5 consecutive years, with $38.6 million as the latest value for Q4 2020.

  • Quarterly Net Cash Flow rose 5300.81% to $38.6 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $51.8 million through Dec 2020, up 2595.06% year-over-year, with the annual reading at $54.7 million for FY2025, 467.55% up from the prior year.
  • Net Cash Flow for Q4 2020 was $38.6 million at Forte Biosciences, up from -$7.6 million in the prior quarter.
  • The five-year high for Net Cash Flow was $69.2 million in Q2 2017, with the low at -$38.9 million in Q4 2017.
  • Average Net Cash Flow over 5 years is $4.2 million, with a median of -$826000.0 recorded in 2016.
  • Peak annual rise in Net Cash Flow hit 14488.82% in 2017, while the deepest fall reached 4175.71% in 2017.
  • Over 5 years, Net Cash Flow stood at -$910000.0 in 2016, then tumbled by 4175.71% to -$38.9 million in 2017, then soared by 144.54% to $17.3 million in 2018, then plummeted by 104.28% to -$742000.0 in 2019, then soared by 5300.81% to $38.6 million in 2020.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at $38.6 million, -$7.6 million, and $10.9 million for Q4 2020, Q3 2020, and Q2 2020 respectively.